CHEK2 and familial papillary or follicular thyroid carcinoma: Several genes and loci, including mainly low-penetrance variants near or in FOXE1, SRGAP1, TITF-1/NKX2-1, DIRC3, and CHEK2, have been suggested to affect non-syndromic FNMTC susceptibility (7, 8).